Urological and Genital Diseases: Haemodialysis Urological and Genital Diseases Haemodialysis
Conditions
Interventions
68 patients will be recruited and randomised into 4 groups. Baseline data on their phosphate knowledge and routine blood chemistry will be obtained. Two groups will attend group education sessions run
Sponsors
Record provided by the NHS Trusts Clinical Trials Register - Department of Health (UK)
Eligibility
Inclusion criteria
Inclusion criteria: Patients will be recruited from Barts and The London NHS Trust haemodialysis population. This includes hospital and satellite units. Inclusion criteria: 1. Serum phosphate: >1.7 mmol/l 2. Serum calcium: 2.2 - 2.6 mmol/l 3. Serum parathyroid hormone (PTH): 10-50 pmol.
Exclusion criteria
Exclusion criteria: Not provided at time of registration
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Group 1 (both interventions): results for phosphate knowledge and serum phosphate control should be the best out of all the groups Groups 2 + 3 (each had one intervention only, group teaching session and intensive clinic respectively): results for phosphate knowledge and serum phosphate control should improve versus baseline Group 4 (control): results for phosphate knowledge and serum phosphate control should be similar to baseline | — |
Secondary
| Measure | Time frame |
|---|---|
| Not provided at time of registration | — |
Countries
United Kingdom
Outcome results
None listed